Bacillus Calmette-Guerin Induces Cellular Reactive Oxygen Species and Lipid Peroxidation in Cancer Cells

被引:12
|
作者
Rahmat, Juwita N.
Esuvaranathan, Kesavan
Mahendran, Ratha [1 ]
机构
[1] Natl Univ Hlth Syst, Dept Urol, Singapore 119228, Singapore
关键词
BLADDER-CANCER; MYCOBACTERIUM-TUBERCULOSIS; COMET ASSAY; DNA-DAMAGE; ANTITUMOR RESPONSE; TUMOR-CELLS; BCG THERAPY; INTERNALIZATION; IMMUNOTHERAPY; ATTACHMENT;
D O I
10.1016/j.urology.2012.01.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine whether Bacillus Calmette-Guerin (BCG) and/or BCG-soluble factors could modulate cellular reactive oxygen species (ROS) in human bladder cancer cells and the impact this could have on response to therapy. METHODS The expression of alpha 5 beta 1 integrins on human bladder cancer cell lines and their ability to internalize BCG were determined. The effect of live and lyophilized BCG on cellular ROS, lipid peroxidation, and DNA damage was determined using H2DCF-DA, TBARS, and comet assays. The cytotoxic effects of live and lyophilized BCG on cancer cells were determined after 24 hours. ROS modulation by Antigen 85B and mycobacterial protein tyrosine phosphatases was monitored. RESULTS Live and lyophilized BCG were internalized to a similar extent, but live BCG increased cellular ROS, whereas lyophilized BCG reduced ROS. High ROS levels correlated with increased lipid peroxidation. The cytotoxic effect of BCG was independent of cellular ROS but dependent on internalization. Lyophilized BCG was more cytotoxic to bladder cancer cells than live BCG. BCG soluble factors such as Antigen85B could increase cellular ROS. Internalization of lyophilized BCG abrogated the ROS, and lipid peroxidation increase induced by BCG soluble factors. Both live and lyophilized BCG induced DNA damage but to different extents. CONCLUSION The end products of ROS, such as lipid peroxides and superoxide, could induce DNA damage, which could lead to mutations in cancer cells that select for their survival. Reducing BCG instillations may reduce the risk of mutational changes occurring in remnant cancer cells. UROLOGY 79: 1411.e15-1411.e20, 2012. (C) 2012 Elsevier Inc.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] CANCER AND BCG (BACILLUS CALMETTE-GUERIN)
    RUMI, LS
    ACTA PHYSIOLOGICA LATINOAMERICANA, 1981, 31 (01) : 25 - 34
  • [2] Bacillus Calmette-Guerin Immunotherapy for Cancer
    Cardillo, Fabiola
    Bonfim, Maiara
    da Silva Vasconcelos Sousa, Periela
    Mengel, Jose
    Ribeiro Castello-Branco, Luiz Roberto
    Pinho, Rosa Teixeira
    VACCINES, 2021, 9 (05)
  • [3] Bacillus Calmette-Guerin and bladder cancer
    Razack, Azad H. A.
    ASIAN JOURNAL OF SURGERY, 2007, 30 (04) : 302 - 309
  • [4] Chronic reactive arthritis associated with Calmette-Guerin bacillus
    Neumayr, C
    Kirchgatterer, A
    Knoflach, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (37) : 1886 - 1888
  • [5] Bacillus Calmette-Guerin induced reactive arthritis - Reply
    Buchs, N
    Chevrel, G
    Miossec, P
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (07) : 1638 - 1638
  • [6] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    UROLOGY, 2019, 124 : 120 - 125
  • [7] The bacillus Calmette-Guerin as immunomodulator in bladder cancer
    Gabriel Vazquez-Lavista, Luis
    Haydee Flores-Balcazar, Christian
    Llorente, Luis
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2007, 59 (02): : 146 - 152
  • [8] Bacillus Calmette-Guerin immunotherapy for genitourinary cancer
    Gandhi, Nilay M.
    Morales, Alvaro
    Lamm, Donald L.
    BJU INTERNATIONAL, 2013, 112 (03) : 288 - 297
  • [9] Intravesical instillation therapy with bacillus Calmette-Guerin for superficial bladder cancer: Study of the mechanism of bacillus Calmette-Guerin immunotherapy
    Shintani, Yasuyo
    Sawada, Yoshihisa
    Inagaki, Takeshi
    Kohjimoto, Yasuo
    Uekado, Yasunari
    Shinka, Toshiaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (02) : 140 - 146
  • [10] Reactive Arthritis After Intravesical Bacillus Calmette-Guerin Therapy
    Taniguchi, Yoshinori
    Nishikawa, Hirofumi
    Kimata, Takahito
    Yoshinaga, Yasuhiko
    Kobayashi, Shigeto
    Terada, Yoshio
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E583 - E588